Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?
Published . Updated .
Covered by 2 outlets: Yahoo Finance, Stocktwits.
Who covered it: Center 1 · Not rated 1. How we rate outlets
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Moderna, Xeris Biopharma, and Vir Biotechnology shares surged to annual highs on Friday as Wall Street optimism grew and markets awaited trial data.
Directly affected
- MRNA Moderna+27.8% 30d
Named in this report.
- XERS Xeris Biopharma Holdings+18.9% 30d
Named in this report.
- VIR Vir Biotechnology+9.8% 30d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-0.8% 18d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Moderna belongs to, so it often moves with news about it.
- AMGN Amgen+10.1% 30d
Amgen is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+15.7% 30d
Gilead Sciences is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-17.1% 12d
argenx SE is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
- BIIB Biogen
Biogen is a peer of Moderna in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MRNA | -13.21% | +1.53% | base | after close | after close | after close | after close |
| XERS | -33.20% | -31.09% | base | after close | after close | after close | after close |
| VIR | -9.79% | -3.56% | base | after close | after close | after close | after close |
| DIA | +1.38% | +4.07% | base | after close | after close | after close | after close |
| QQQ | +3.80% | +5.39% | base | after close | after close | after close | after close |
| XLV | -0.10% | +2.63% | base | after close | after close | after close | after close |
| AMGN | +1.13% | +3.87% | base | after close | after close | after close | after close |
| GILD | +2.11% | +4.54% | base | after close | after close | after close | after close |
| ARGX | -5.82% | +0.29% | base | after close | after close | after close | after close |
| RVMD | -2.15% | +3.75% | base | after close | after close | after close | after close |
| BIIB | +0.18% | +2.45% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week? Yahoo Finance
Source: Yahoo Finance
Spdr Dow Jones Industrial Average Etf Trust (DIA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | +3.87% | final price |
| AMGN | five days earlier | +1.13% | final price |
| ARGX | three days earlier | +0.29% | final price |
| ARGX | five days earlier | -5.82% | final price |
| BIIB | three days earlier | +2.45% | final price |
| BIIB | five days earlier | +0.18% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | three days earlier | +4.07% | final price |
| Spdr Dow Jones Industrial Average Etf Trust (DIA) | five days earlier | +1.38% | final price |
| GILD | three days earlier | +4.54% | final price |
| GILD | five days earlier | +2.11% | final price |
| MRNA | three days earlier | +1.53% | final price |
| MRNA | five days earlier | -13.21% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +5.39% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +3.80% | final price |
| RVMD | three days earlier | +3.75% | final price |
| RVMD | five days earlier | -2.15% | final price |
| VIR | three days earlier | -3.56% | final price |
| VIR | five days earlier | -9.79% | final price |
| XERS | three days earlier | -31.09% | final price |
| XERS | five days earlier | -33.20% | final price |
| XLV | three days earlier | +2.63% | final price |
| XLV | five days earlier | -0.10% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 25 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 48 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 75 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Biogen (BIIB), worth $1,001 - $15,000 on 24 Sep 2026. That is 46 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Biogen (BIIB) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 66 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Biogen (BIIB), worth $1,001 - $15,000 on 18 Aug 2026. That is 83 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies tied to this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
In “Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
In “Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- IWM Ishares Tr
For “Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
In “Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
- VTI Vanguard Index Fds
Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence in the 9 Nov 2026 story “Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?.” Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Spdr Dow Jones Industrial Average Etf Trust (DIA)
“Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?” (9 Nov 2026) reaches Spdr Dow Jones Industrial Average Etf Trust (DIA) through this story.
For Spdr Dow Jones Industrial Average Etf Trust (DIA), the reason on file says SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Also listed, Invesco Qqq Trust, Series 1 (QQQ): Invesco QQQ: it is a broad US stock-market fund. Linked by “stocks” (the broad US market) in this story
Dates in the story, and the Spdr Dow Jones Industrial Average Etf Trust (DIA) price range
DIA traded between 504.92 and 522.62 across 13 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 285.25 across 20 sessions. The latest close on file is 279.20. QQQ traded between 680.34 and 757.18 across 20 sessions. The latest close on file is 685.32.
How strong the case is around Spdr Dow Jones Industrial Average Etf Trust (DIA)
47 out of 100
“Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week?” scores 47 out of 100. The score uses 2 sources, and 5 linked companies.